SBI Securities
AXDX icon

SBI Securities’s Accelerate Diagnostics AXDX Stock Holding History

SBI Securities’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3
Closed -$2 – 4147
2025
Q1 		$2 Buy
+3
New +$3 ﹤0.01% 4082

Other funds holding AXDX

BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Bartlett & Co Wealth Management
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

SBI Securities's AXDX Position: Q2 2025 in Review

SBI Securities sold out of Accelerate Diagnostics (AXDX) in Q2 2025, closing a stake of 3 shares — an estimated $2 sold.

SBI Securities first reported a position in AXDX in Q1 2025 and held it in 1 quarter. The position peaked at $2 in Q1 2025. 3 funds tracked by Wall St. Rank hold AXDX as of Q2 2025.

  • SBI Securities reported no remaining Accelerate Diagnostics position as of Q2 2025 after selling out during the quarter.
  • SBI Securities sold 3 Accelerate Diagnostics shares in Q2 2025, an estimated $2.
  • SBI Securities first reported a position in Accelerate Diagnostics in Q1 2025 and held it in 1 quarter.
  • SBI Securities's Accelerate Diagnostics position peaked at $2 in Q1 2025.
  • 3 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2025.

Based on SBI Securities's 13F filing for Q2 2025, filed 8 Aug 2025.